Syneron Medical Ltd (ELOS) Reports In-Line Q4 EPS
Get Alerts ELOS Hot Sheet
Join SI Premium – FREE
Syneron Medical Ltd (NASDAQ: ELOS) reported Q4 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $78.9 million versus the consensus estimate of $75.56 million.
For earnings history and earnings-related data on Syneron Medical Ltd (ELOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- Deutsche Bank Reiterates Buy Rating on Target (TGT), Adds to Q2 Fresh Money List
- Stran & Company, Inc. (SWAG) Misses Q4 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!